Modulation of TNFα, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors
Tóm tắt
Từ khóa
Tài liệu tham khảo
Parks RJ, Bramson JL, Wan Y, Addison CL, Graham FL . Effects of stuffer DNA on transgene expression from helper-dependent adenovirus vectors. J Virol 1999; 73: 8027–8034.
Hotchkiss RS, Karl IE . The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348: 138–150.
Morral N, O'Neal WK, Rice K, Leland MM, Piedra PA, Aguilar-Cordova E et al. Lethal toxicity, severe endothelial injury, and a threshold effect with high doses of an adenoviral vector in baboons. Hum Gene Ther 2002; 13: 143–154.
Abuzakouk M, Feighery C, Jackson J . Tumour necrosis factor blocking agents: a new therapeutic modality for inflammatory disorders. Br J Biomed Sci 2002; 59: 173–179.
Hull KM, Shoham N, Chae JJ, Aksentijevich I, Kastner DL . The expanding spectrum of systemic autoinflammatory disorders and their rheumatic manifestations. Curr Opin Rheumatol 2003; 15: 61–69.
Brunetti-Pierri N, Palmer DJ, Mane V, Finegold M, Beaudet AL, Ng P . Increased hepatic transduction with reduced systemic dissemination and proinflammatory cytokines following hydrodynamic injection of helper-dependent adenoviral vectors. Mol Ther 2005; 12: 99–106.
Zhang Y, Chirmule N, Gao GP, Qian R, Croyle M, Joshi B et al. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages. Mol Ther 2001; 3: 697–707.
Schnell MA, Zhang Y, Tazelaar J, Gao GP, Yu QC, Qian R et al. Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors. Mol Ther 2001; 3: 708–722.
Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148–158.
Liu Q, Zaiss AK, Colarusso P, Patel K, Haljan G, Wickham TJ et al. The role of capsid-endothelial interactions in the innate immune response to adenovirus vectors. Hum Gene Ther 2003; 14: 627–643.
Morral N, Parks RJ, Zhou H, Langston C, Schiedner G, Quinones J et al. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity. Hum Gene Ther 1998; 9: 2709–2716.
Reddy PS, Sakhuja K, Ganesh S, Yang L, Kayda D, Brann T et al. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol Ther 2002; 5: 63–73.
Muruve DA, Cotter MJ, Zaiss AK, White LR, Liu Q, Chan T et al. Helper-dependent adenovirus vectors elicit intact innate but attenuated adaptive host immune responses in vivo. J Virol 2004; 78: 5966–5972.
O'Neal WK, Zhou H, Morral N, Aguilar-Cordova E, Pestaner J, Langston C et al. Toxicological comparison of E2a-deleted and first-generation adenoviral vectors expressing alpha1-antitrypsin after systemic delivery. Hum Gene Ther 1998; 9: 1587–1598.
Cichon G, Schmidt HH, Benhidjeb T, Loser P, Ziemer S, Haas R et al. Intravenous administration of recombinant adenoviruses causes thrombocytopenia, anemia and erythroblastosis in rabbits. J Gene Med 1999; 1: 360–371.
Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ et al. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Hum Gene Ther 2002; 13: 163–175.
Klinger JR, Sanchez MP, Curtin LA, Durkin M, Matyas B . Multiple cases of life-threatening adenovirus pneumonia in a mental health care center. Am J Respir Crit Care Med 1998; 157: 645–649.
Eggerman TL, Mondoro TH, Lozier JN, Vostal JG . Adenoviral vectors do not induce, inhibit, or potentiate human platelet aggregation. Hum Gene Ther 2002; 13: 125–128.
Faraday N, Rade JJ, Johns DC, Khetawat G, Noga SJ, DiPersio JF et al. Ex vivo cultured megakaryocytes express functional glycoprotein IIb–IIIa receptors and are capable of adenovirus-mediated transgene expression. Blood 1999; 94: 4084–4092.
Brunetti-Pierri N, Palmer DJ, Beaudet AL, Carey KD, Finegold M, Ng P . Acute toxicity after high-dose systemic injection of helper-dependent adenoviral vectors into nonhuman primates. Hum Gene Ther 2004; 15: 35–46.
Sung RS, Qin L, Bromberg JS . TNFalpha and IFNgamma induced by innate anti-adenoviral immune responses inhibit adenovirus-mediated transgene expression. Mol Ther 2001; 3: 757–767.
Goodbourn S, Didcock L, Randall RE . Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures. J Gen Virol 2000; 81: 2341–2364.
Elkon KB, Liu CC, Gall JG, Trevejo J, Marino MW, Abrahamsen KA et al. Tumor necrosis factor alpha plays a central role in immune-mediated clearance of adenoviral vectors. Proc Natl Acad Sci USA 1997; 94: 9814–9819.
Trevejo JM, Marino MW, Philpott N, Josien R, Richards EC, Elkon KB et al. TNF-alpha -dependent maturation of local dendritic cells is critical for activating the adaptive immune response to virus infection. Proc Natl Acad Sci USA 2001; 98: 12162–12167.
Piguet PF, Vesin C, Da Kan C . Activation of platelet caspases by TNF and its consequences for kinetics. Cytokine 2002; 18: 222–230.
Piguet PF, Vesin C, Guo J, Donati Y, Barazzone C . Role of mast cells and monoamines in the thrombocytopaenia and mortality elicited by tumour necrosis factor in mice. Immunology 1998; 95: 111–116.
Derkx B, Taminiau J, Radema S, Stronkhorst A, Wortel C, Tytgat G et al. Tumour-necrosis-factor antibody treatment in Crohn's disease. Lancet 1993; 342: 173–174.
Feldmann M, Brennan FM, Maini RN . Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 1996; 14: 397–440.
Brunetti-Pierri N, Nichols TC, McCorquodale S, Merricks E, Palmer DJ, Beaudet AL et al. Sustained phenotypic correction of canine hemophilia B after systemic administration of helper-dependent adenoviral vector. Hum Gene Ther 2005; 16: 811–820.
Varnavski AN, Calcedo R, Bove M, Gao G, Wilson JM . Evaluation of toxicity from high-dose systemic administration of recombinant adenovirus vector in vector-naive and pre-immunized mice. Gene Ther 2005; 12: 427–436.
Benihoud K, Salone B, Esselin S, Opolon P, Poli V, Di Giovine M et al. The role of IL-6 in the inflammatory and humoral response to adenoviral vectors. J Gene Med 2000; 2: 194–203.
Thorne PS, McCray PB, Howe TS, O'Neill MA . Early-onset inflammatory responses in vivo to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflammation. Am J Respir Cell Mol Biol 1999; 20: 1155–1164.
Lozier JN, Csako G, Mondoro TH, Krizek DM, Metzger ME, Costello R et al. Toxicity of a first-generation adenoviral vector in rhesus macaques. Hum Gene Ther 2002; 13: 113–124.
Murray KM, Dahl SL . Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis. Ann Pharmacother 1997; 31: 1335–1338.
Grounds MD, Davies M, Torrisi J, Shavlakadze T, White J, Hodgetts S . Silencing TNFalpha activity by using Remicade or Enbrel blocks inflammation in whole muscle grafts: an in vivo bioassay to assess the efficacy of anti-cytokine drugs in mice. Cell Tissue Res 2005; 320: 509–515.
Higginbotham JN, Seth P, Blaese RM, Ramsey WJ . The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid. Hum Gene Ther 2002; 13: 129–141.
Benihoud K, Yeh P, Perricaudet M . Adenovirus vectors for gene delivery. Curr Opin Biotechnol 1999; 10: 440–447.
Yotnda P, Chen DH, Chiu W, Piedra PA, Davis A, Templeton NS et al. Bilamellar cationic liposomes protect adenovectors from preexisting humoral immune responses. Mol Ther 2002; 5: 233–241.
Croyle MA, Chirmule N, Zhang Y, Wilson JM . PEGylation of E1-deleted adenovirus vectors allows significant gene expression on readministration to liver. Hum Gene Ther 2002; 13: 1887–1900.
Mok H, Palmer DJ, Ng P, Barry MA . Evaluation of polyethylene glycol modification of first-generation and helper-dependent adenoviral vectors to reduce innate immune responses. Mol Ther 2005; 11: 66–79.
Croyle MA, Le HT, Linse KD, Cerullo V, Toietta G, Beaudet A et al. PEGylated helper-dependent adenoviral vectors: highly efficient vectors with an enhanced safety profile. Gene Therapy 2005; 12: 579–587.
Tao N, Gao GP, Parr M, Johnston J, Baradet T, Wilson JM et al. Sequestration of adenoviral vector by Kupffer cells leads to a nonlinear dose response of transduction in liver. Mol Ther 2001; 3: 28–35.
Schiedner G, Hertel S, Johnston M, Dries V, van Rooijen N, Kochanek S . Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors. Mol Ther 2003; 7: 35–43.
Body JJ, Diel I, Bell R . Profiling the safety and tolerability of bisphosphonates. Semin Oncol 2004; 31: 73–78.
Spencer AJ, Wilson SA, Batchelor J, Reid A, Rees J, Harpur E . Gadolinium chloride toxicity in the rat. Toxicol Pathol 1997; 25: 245–255.
Gooding LR . Regulation of TNF-mediated cell death and inflammation by human adenoviruses. Infect Agents Dis 1994; 3: 106–115.
Varnavski AN, Zhang Y, Schnell M, Tazelaar J, Louboutin JP, Yu QC et al. Preexisting immunity to adenovirus in rhesus monkeys fails to prevent vector-induced toxicity. J Virol 2002; 76: 5711–5719.
Ng P, Parks RJ, Cummings DT, Evelegh CM, Graham FL . An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method. Hum Gene Ther 2000; 11: 693–699.